Crossmark

The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study

Crossref DOI link: https://doi.org/10.1007/s10147-021-01872-5

Published Online: 2021-01-20

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kato, Taigo http://orcid.org/0000-0002-8681-1407
Nagahara, Akira

Kawamura, Norihiko

Nakata, Wataru

Soda, Tetsuji

Matsuzaki, Kyosuke

Hatano, Koji

Kawashima, Atsunari

Ujike, Takeshi

Imamura, Ryoichi

Nishimura, Kensaku

Takada, Shingo

Tsujihata, Masao

Yamaguchi, Seiji

Takao, Tetsuya

Nishimura, Kazuo

Nonomura, Norio

Uemura, Motohide
License Information

Text and Data Mining valid from 2021-01-20

Version of Record valid from 2021-01-20
More Information

Article History

Received: 12 October 2020

Accepted: 3 January 2021

First Online: 20 January 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below